The Wall Street Journal

Also in WSJ.com:

International Editions

Market Data

C.R. Bard Inc. BCR (U.S.: NYSE)

View All companies

AT CLOSE 4:01 PM ET 09/10/14
^$149.19 USD
0.35 0.24%
Volume 280,240

AFTER HOURS 4:39 PM ET 09/10/14
^$149.079 -0.111 -0.07%
AFTER HOURS Vol 922

Volume 280,240
65 Day Avg Vol 636,063
1 Day Range 148.81 - 149.59
52 Week Range 113.52 - 154.16 (10/03/13 - 07/28/14)

Compare

Compare to Benchmark:
DJIA
S&P 500
GLOBAL DOW
NASDAQ
Health Care

Today's Open 148.98
Prior Day Close 148.84 (09/09/14)

Performance Today
BCR 0.24%
DJIA 0.32%
S&P 500 0.36%
Health Care 0.75%

Latest News C.R. Bard Inc.(BCR)

- 07/24/14
- Press Release
Bard Announces Second Quarter Results
- Press Release
- 07/01/14
- Press Release
Bard to Host Earnings Conference Call on July 24, 2014
- Press Release
- 06/30/14
- Press Release
Collaborations, Critical Takeover Decisions, Quarterly Dividends, and Litigation Settlements - Analyst Notes on Bristol-Myers, Allergan, Bard, Perrigo and Health Net
- Press Release
- 06/18/14
- Dow Jones Newswires
CR Bard Cut to Equalweight From Overweight by Barclays
- Dow Jones Newswires
- 06/13/14
- Dow Jones Newswires
U.S. Hot Stocks: Hot Stocks to Watch
- Dow Jones Newswires
- 06/12/14
- Dow Jones Newswires
U.S. FDA Panel Recommends Use of Lutonix Drug-Coated Balloon
- Dow Jones Newswires
- 06/12/14
- Press Release
Circulatory System Devices Advisory Panel Provides a Unanimous Favorable Recommendation to FDA for the Lutonix(R) Drug Coated Balloon
- Press Release
- 06/12/14
- WSJ Blogs
Stocks to Watch: Lululemon, Restoration Hardware, Geron
- WSJ Blogs
- 06/12/14
- Dow Jones Newswires
U.S. Hot Stocks: Hot Stocks to Watch
- Dow Jones Newswires
- 06/11/14
- Dow Jones Newswires
C.R. Bard Raises Dividend 4.8%, Approves Additional $500 Million for Stock Buybacks
- Dow Jones Newswires
- 06/11/14
- Press Release
Bard Announces $500 Million Share Repurchase Authorization
- Press Release
- 06/11/14
- Press Release
Bard Increases Quarterly Dividend
- Press Release
- 06/10/14
- Press Release
Health Care Sector Stocks Technical Study -- Research on CR Bard, Quest Diagnostics, Laboratory Corp. of America, and Allscripts Healthcare Solutions
- Press Release
- 06/09/14
- Press Release
Public Offerings, Product Launches, and Upcoming Conferences - Analyst Notes on Insulet, CR Bard, Covidien, Thoratec and Hill-Rom
- Press Release
- 05/21/14
- Press Release
Conference Schedules, Acquisition Updates, Global Footprints, and Technical Updates - Analyst Notes on Forest, CR Bard, Mallinckrodt, Covidien and WellPoint
- Press Release
- 05/15/14
- Press Release
Equity Coverage on Health Care Sector Equities -- Research on Mindray Medical Intl., CareFusion, Covidien, and CR Bard
- Press Release
- 04/30/14
- Press Release
Bard to Present at the Bank of America Merrill Lynch Healthcare Conference
- Press Release
- 04/28/14
- Press Release
Strategic Collaborations, Fresh Agreements, and Upcoming Conferences - Analyst Notes on Biogen, Bristol-Myers, AbbVie, Actavis and Bard
- Press Release
- 04/23/14
- Press Release
Bard to Present at the Deutsche Bank Healthcare Conference
- Press Release
- 04/22/14
- Press Release
Bard Announces First Quarter Results
- Press Release
- 04/21/14
- Press Release
Technical Commentary on Health Care Sector Equities -- Research on CR Bard, DENTSPLY Intl., CareFusion, and Mindray Medical Intl.
- Press Release
- 04/16/14
- Press Release
Bard Declares Quarterly Dividend
- Press Release
- 04/10/14
- Press Release
Acquisitions, Trial Study Results, Drug Trend Reports, Conference Call Schedules, and Product Launches - Analyst Notes on Mallinckrodt, Amgen, Express Scripts, CR Bard, and Jazz
- Press Release
- 04/04/14
- Press Release
New Products, Dividends, Upcoming Conference Calls, and Leadership Changes - Analyst Notes on Intuitive Surgical, Agilent, Bard, St. Jude Medical, and Stryker
- Press Release
- 04/01/14
- Press Release
Bard to Host Earnings Conference Call on April 22, 2014
- Press Release
- 03/28/14
- Press Release
Healthcare Companies Make Presentations, Submissions, Investigation Extensions, and Expansions - Analyst Notes on CR Bard, Medivation, Align Technology, Covance, and PAREXEL
- Press Release
- 01/25/14
- Barron's
Hey, Big Spender!
- Barron's
- 01/25/14
- Barron's
Hey, Big Spender!
- Barron's
- 01/06/14
- Dow Jones Newswires
CR Bard Cut to Neutral From Overweight by JPMorgan
- Dow Jones Newswires
- 12/28/13
- Barron's
Our Small-Cap Picks Smoked the Market
- Barron's
- 10/19/13
- Barron's
13D Filings
- Barron's
- 09/14/13
- Barron's
13D Filings
- Barron's
- 06/01/13
- Barron's
Preview
- Barron's
- 05/14/13
- The Wall Street Journal
C.R. Bard to Pay $48.3 Million to Settle Kickback Case -DOJ
- The Wall Street Journal

Key Stock Data

P/E Ratio (TTM): The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for the trailing 12 month period.
Earnings Per Share (TTM): A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding.
Market Capitalization: Reflects the total market value of a company. Market Cap is calculated by multiplying the number of shares outstanding by the stock's price. For companies with multiple common share classes, market capitalization includes both classes.
Shares Outstanding: Number of shares that are currently held by investors, including restricted shares owned by the company's officers and insiders as well as those held by the public.
Public Float: The number of shares in the hands of public investors and available to trade. To calculate, start with total shares outstanding and subtract the number of restricted shares. Restricted stock typically is that issued to company insiders with limits on when it may be traded.
Dividend Yield: A company's dividend expressed as a percentage of its current stock price.

Key Stock Data

P/E Ratio (TTM)
15.04 (09/10/2014)
EPS (TTM)
^$9.92
Market Cap
^$11.13 B
Shares Outstanding
74.64 M
Public Float
73.97 M
Yield
0.59% (09/10/2014)
Latest Dividend
^$0.22 (08/01/2014)
Ex-Dividend Date
07/17/2014

Shares Sold Short: The total number of shares of a security that have been sold short and not yet repurchased.
Change from Last: Percentage change in short interest from the previous report to the most recent report. Exchanges report short interest twice a month.
Percent of Float: Total short positions relative to the number of shares available to trade.

Short Interest

Shares Sold Short
2.40 M (08/29/2014)
Change from Last
-15.18%
Percent of Float
3.24%

Money Flow Uptick/Downtick Ratio: Money flow measures the relative buying and selling pressure on a stock, based on the value of trades made on an "uptick" in price and the value of trades made on a "downtick" in price. The up/down ratio is calculated by dividing the value of uptick trades by the value of downtick trades. Net money flow is the value of uptick trades minus the value of downtick trades. Our calculations are based on comprehensive, delayed quotes.

Stock Money Flow

Competitors (BCR)

Company	Change	P/E (TTM)
BDX Becton Dickinson & Co.	-0.45% -0.52	22.87
TFX Teleflex Inc.	-0.17% -0.19	27.58
CNMD CONMED Corp.	-0.28% -0.11	30.91
COLOB Coloplast A/S Series B	+1.02% +4.90	44.45
BSX Boston Scientific Corp.	+1.05% +0.13	69.77
EW Edwards Lifesciences Corp.	+1.46% +1.45	14.10
COH Cochlear Ltd.	-0.29% -0.20	41.42
STMN Straumann Holding AG	+0.27% +0.60	30.64
DXCM DexCom Inc.	+1.88% +0.80	-
CFN CareFusion Corp.	+1.05% +0.48	23.30

Competitor Data Provided By: capital cube

Profile (BCR)

C.R. Bard, Inc. designs, manufactures, distributes and sells medical, surgical, diagnostic and patient care devices. The company operates its business through only one segment, manufacturing and selling of medical devices. It sells a broad range of products to hospitals,...

730 Central Avenue
Murray Hill New Jersey 07974
United States

Website
Map

Employees 13,000

Sector Medical Supplies
Sales or Revenue 3.05 B

Industry Health Care
1Y Sales Change 3.09%

Fiscal Year Ends December 31 Download Reports

Tim M. Ring Chairman & Chief Executive Officer

John H. Weiland President, Chief Operating Officer & Director

Christopher S. Holland Chief Financial Officer & Senior Vice President

Patrick D. Roche Vice President-Information Technology Solutions

Research & Ratings C.R. Bard Inc.(BCR)

Per-Share Earnings, Actuals and Estimates

BCR will report Q3 earnings on 10/21/2014

Actual Analyst Range Consensus

3.00 2.00 1.00 0.00

Actual 1.50 1.40	Actual 1.61 1.39	Actual 1.91 1.86	Actual 2.06 2.00		2.10	2.26
Q32013	Q4	Q12014	Q2		Q3	Q4

Q3 2014 Estimate Trends
Current:	^$2.10
1 month ago:	^$2.10
3 months ago:	^$2.09

Q4 2014 Estimate Trends
Current:	^$2.26
1 month ago:	^$2.26
3 months ago:	^$2.26

FY 2014 Estimate Trends
Current:	^$8.31
1 month ago:	^$8.31
3 months ago:	^$8.26

FY 2015 Estimate Trends
Current:	^$9.22
1 month ago:	^$9.23
3 months ago:	^$9.20

Financials C.R. Bard Inc.(BCR)

Net Income

0 300M 600M 900M

0 -300M

Jun 2013 Sep 2013 Dec 2013 Mar 2014 Jun 2014

Jun 2014

5-quarter trend

Net Income Growth

+26.11%

Sales or Revenue

827.10 M

Sales or Revenue Growth

+8.84%

EBITDA

+239.20 M

Notes & Data Providers

Real-time U.S. stock quotes reflect trades reported through Nasdaq only. U.S. stock quote data and real-time U.S. stock indexes provided by Dow Jones.

International stock quotes are delayed as per exchange requirements. Indexes may be real-time or delayed; refer to time stamps on index quote pages for information on delay times.

Quote data, except U.S. stocks, provided by SIX Financial Information.

Data is provided "as is" for informational purposes only and is not intended for trading purposes. SIX Financial Information (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. Data may be intentionally delayed pursuant to supplier requirements.

Bond quotes are updated in real-time. Source: Tullett Prebon PLC, ICAP PLC.

Currency quotes are updated in real-time. Source: ICAP PLC.

Actual 8.39 5.75	8.31	9.22	10.10
FY 2013	FY 2014	FY 2015	FY 2016

C.R. Bard Inc. BCR (U.S.: NYSE)

AT CLOSE 4:01 PM ET 09/10/14

Volume 280,240

AFTER HOURS 4:39 PM ET 09/10/14

AFTER HOURS Vol 922

Latest News C.R. Bard Inc.(BCR)

Key Stock Data

P/E Ratio (TTM)

EPS (TTM)

Market Cap

Shares Outstanding

Public Float

Yield

Latest Dividend

Ex-Dividend Date

Short Interest

Shares Sold Short

Change from Last

Percent of Float

Stock Money Flow

Competitors (BCR)

Per-Share Earnings, Actuals and Estimates

Net Income

Customer Service

Policy

Ads

Tools & Features

More